FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072646046> ?p ?o ?g. }

• W2072646046 endingPage "2114" @default.
• W2072646046 startingPage "2106" @default.
• W2072646046 abstract "Oligonucleotides containing CpG motifs and immunomodulatory oligonucleotides (IMO) containing a synthetic immunostimulatory dinucleotide and a novel DNA structure have been suggested to have potential for the treatment of various human diseases. In the present study, a newly designed IMO was evaluated in several models of human (MCF-7 and BT474 xenograft) and murine (4T1 syngeneic) breast cancer. Pharmacokinetics studies of the IMO administered by s.c., i.v., p.o., or i.p. routes were also accomplished. The IMO was widely distributed to various tissues by all four routes, with s.c. administration yielding the highest concentration in tumor tissue. The IMO inhibited the growth of tumors in all three models of breast cancer, with the lowest dose of the IMO inhibiting MCF-7 xenograft tumor growth by >40%. Combining the IMO with the anticancer antibody, Herceptin, led to potent antitumor effects, resulting in >96% inhibition of tumor growth. The IMO also exerted in vitro antitumor activity, as measured by cell growth, apoptosis, and proliferation assays in the presence of Lipofectin. This is the first report of the pharmacokinetics of this agent in normal and tumor-bearing mice. Based on the present results, we believe that the IMO is a good candidate for clinical development for breast cancer therapy used either alone or in combination with conventional cancer therapeutic agents." @default.
• W2072646046 created "2016-06-24" @default.
• W2072646046 creator A5046597133 @default.
• W2072646046 creator A5069014764 @default.
• W2072646046 creator A5084240742 @default.
• W2072646046 creator A5088791437 @default.
• W2072646046 creator A5088978867 @default.
• W2072646046 creator A5090366405 @default.
• W2072646046 date "2006-08-01" @default.
• W2072646046 modified "2023-09-24" @default.
• W2072646046 title "Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics,<i>in vitro</i>and<i>in vivo</i>anticancer activity, and potentiation of antibody therapy" @default.
• W2072646046 cites W1514540900 @default.
• W2072646046 cites W1551211023 @default.
• W2072646046 cites W1656835564 @default.
• W2072646046 cites W177424519 @default.
• W2072646046 cites W1935511302 @default.
• W2072646046 cites W1970291282 @default.
• W2072646046 cites W1975992370 @default.
• W2072646046 cites W1977788444 @default.
• W2072646046 cites W1984930006 @default.
• W2072646046 cites W1986877571 @default.
• W2072646046 cites W1994489381 @default.
• W2072646046 cites W1999416824 @default.
• W2072646046 cites W2007835300 @default.
• W2072646046 cites W2012489369 @default.
• W2072646046 cites W2020709177 @default.
• W2072646046 cites W2022617758 @default.
• W2072646046 cites W2023955378 @default.
• W2072646046 cites W2032967017 @default.
• W2072646046 cites W2033063638 @default.
• W2072646046 cites W2033441782 @default.
• W2072646046 cites W2033476185 @default.
• W2072646046 cites W2033482581 @default.
• W2072646046 cites W203370464 @default.
• W2072646046 cites W2038708057 @default.
• W2072646046 cites W2040921284 @default.
• W2072646046 cites W2042017272 @default.
• W2072646046 cites W2045895711 @default.
• W2072646046 cites W2056092077 @default.
• W2072646046 cites W2062620592 @default.
• W2072646046 cites W2064235131 @default.
• W2072646046 cites W2067839818 @default.
• W2072646046 cites W2068515672 @default.
• W2072646046 cites W2070364388 @default.
• W2072646046 cites W2071754972 @default.
• W2072646046 cites W2074851687 @default.
• W2072646046 cites W2077818976 @default.
• W2072646046 cites W2082143240 @default.
• W2072646046 cites W2091905924 @default.
• W2072646046 cites W2096882511 @default.
• W2072646046 cites W2097755672 @default.
• W2072646046 cites W2105404910 @default.
• W2072646046 cites W2106986504 @default.
• W2072646046 cites W2107277505 @default.
• W2072646046 cites W2111819461 @default.
• W2072646046 cites W2115267868 @default.
• W2072646046 cites W2117445564 @default.
• W2072646046 cites W2119792005 @default.
• W2072646046 cites W2126767360 @default.
• W2072646046 cites W2133449490 @default.
• W2072646046 cites W2139029604 @default.
• W2072646046 cites W2140724157 @default.
• W2072646046 cites W2149944230 @default.
• W2072646046 cites W2161228679 @default.
• W2072646046 cites W2161419307 @default.
• W2072646046 cites W2168522148 @default.
• W2072646046 doi "https://doi.org/10.1158/1535-7163.mct-06-0158" @default.
• W2072646046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16928832" @default.
• W2072646046 hasPublicationYear "2006" @default.
• W2072646046 type Work @default.
• W2072646046 sameAs 2072646046 @default.
• W2072646046 citedByCount "34" @default.
• W2072646046 countsByYear W20726460462012 @default.
• W2072646046 countsByYear W20726460462013 @default.
• W2072646046 countsByYear W20726460462014 @default.
• W2072646046 countsByYear W20726460462015 @default.
• W2072646046 countsByYear W20726460462016 @default.
• W2072646046 countsByYear W20726460462017 @default.
• W2072646046 countsByYear W20726460462019 @default.
• W2072646046 countsByYear W20726460462020 @default.
• W2072646046 countsByYear W20726460462022 @default.
• W2072646046 countsByYear W20726460462023 @default.
• W2072646046 crossrefType "journal-article" @default.
• W2072646046 hasAuthorship W2072646046A5046597133 @default.
• W2072646046 hasAuthorship W2072646046A5069014764 @default.
• W2072646046 hasAuthorship W2072646046A5084240742 @default.
• W2072646046 hasAuthorship W2072646046A5088791437 @default.
• W2072646046 hasAuthorship W2072646046A5088978867 @default.
• W2072646046 hasAuthorship W2072646046A5090366405 @default.
• W2072646046 hasConcept C112705442 @default.
• W2072646046 hasConcept C121608353 @default.
• W2072646046 hasConcept C126322002 @default.
• W2072646046 hasConcept C150903083 @default.
• W2072646046 hasConcept C185592680 @default.
• W2072646046 hasConcept C202751555 @default.
• W2072646046 hasConcept C207001950 @default.
• W2072646046 hasConcept C2776999253 @default.
• W2072646046 hasConcept C502942594 @default.

• next